Low molecular weight heparin prophylaxis to prevent VTE events in hospitalized oncology patients.

Low molecular weight heparin is a well-supported prophylactic option to effectively reduce the risk of VTE events in hospitalized oncology patients, with guidelines endorsing its use during hospital stays.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24344982
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Low molecular weight heparin prophylaxis to prevent VTE events in hospitalized oncology patients.

Tripdatabase
9 links
Zenodo (CERN European Organization for Nuclear Research)
Venous Thromboembolism Diagnosis and Management
article

Low molecular weight heparin prophylaxis to prevent VTE events in hospitalized oncology patients.

Tripdatabase
article en

Abstract

Low molecular weight heparin is a well-supported prophylactic option to effectively reduce the risk of VTE events in hospitalized oncology patients, with guidelines endorsing its use during hospital stays.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon